Nanotechnology against COVID-19: Immunization, diagnostic and therapeutic studies
A Hasanzadeh, M Alamdaran, S Ahmadi… - Journal of Controlled …, 2021 - Elsevier
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in early
2020 soon led to the global pandemic of Coronavirus Disease 2019 (COVID-19). Since …
2020 soon led to the global pandemic of Coronavirus Disease 2019 (COVID-19). Since …
[HTML][HTML] Pathophysiology of fibrosis in the vocal fold: current research, future treatment strategies, and obstacles to restoring vocal fold pliability
Y Kumai - International journal of molecular sciences, 2019 - mdpi.com
Communication by voice depends on symmetrical vibrations within the vocal folds (VFs) and
is indispensable for various occupations. VF scarring is one of the main reasons for …
is indispensable for various occupations. VF scarring is one of the main reasons for …
[HTML][HTML] Photochemical internalization of siRNA for cancer therapy
LMA Ali, M Gary-Bobo - Cancers, 2022 - mdpi.com
Simple Summary The objective of this review is to focus on the different nanovectors
capable of transporting genetic material such as small-interfering RNA (siRNA) in order to …
capable of transporting genetic material such as small-interfering RNA (siRNA) in order to …
[HTML][HTML] EGFR-targeted cellular delivery of therapeutic nucleic acids mediated by boron clusters
D Kaniowski, J Suwara, K Ebenryter-Olbińska… - International Journal of …, 2022 - mdpi.com
New boron carriers with high boron content and targeted cancer-cell delivery are considered
the first choice for boron neutron capture therapy (BNCT) for cancer treatment. Previously …
the first choice for boron neutron capture therapy (BNCT) for cancer treatment. Previously …
Targeted nanomedicine with anti-EGFR scFv for siRNA delivery into triple negative breast cancer cells
PV Nguyen, K Hervé-Aubert, S David, N Lautram… - European Journal of …, 2020 - Elsevier
A targeted nanomedicine with humanized anti-EGFR scFv (NM-scFv) was developed for
siRNA delivery into triple negative breast cancer (TNBC) cells. NM-scFv consisted of i) …
siRNA delivery into triple negative breast cancer (TNBC) cells. NM-scFv consisted of i) …
[HTML][HTML] Liposomal siRNA formulations for the treatment of herpes simplex virus-1: in vitro characterization of physicochemical properties and activity, and in vivo …
D Jbara-Agbaria, S Blondzik, A Burger-Kentischer… - Pharmaceutics, 2022 - mdpi.com
Herpes simplex virus-1 (HSV-1) is highly contagious, and there is a need for a therapeutic
means to eradicate it. We have identified an siRNA (siHSV) that knocks down gene …
means to eradicate it. We have identified an siRNA (siHSV) that knocks down gene …
[HTML][HTML] COVID-19 mitigation: nanotechnological intervention, perspective, and future scope
A Adhikari, D Mandal, D Rana, J Nath, A Bose… - Materials …, 2023 - pubs.rsc.org
COVID-19 infections and severe acute respiratory syndrome (SARS) have caused an
unprecedented health crisis across the globe with numerous deaths, as well as causing a …
unprecedented health crisis across the globe with numerous deaths, as well as causing a …
Current approaches to management of vocal fold scar
J Allen - Current Opinion in Otolaryngology & Head and Neck …, 2021 - journals.lww.com
VF fibrosis research continues to expand and explore a variety of mechanistic pathways in
order to understand VF healing and identify novel and complementary targets for …
order to understand VF healing and identify novel and complementary targets for …
SMAD3 expression and regulation of fibroplasia in vocal fold injury
N Hiwatashi, PA Benedict, GR Dion, R Bing… - The …, 2017 - Wiley Online Library
Objective Recent reports highlight the efficacy of small interfering RNA (siRNA) targeting
SMAD3 to regulate transforming growth factor β (TGF‐β)‐mediated fibroplasia in vocal fold …
SMAD3 to regulate transforming growth factor β (TGF‐β)‐mediated fibroplasia in vocal fold …
Special Focus Issue Part II: Recruitment of solid lipid nanoparticles for the delivery of CRISPR/Cas9: primary evaluation of anticancer gene editing
Aim: The CRISPR/Cas9 system is a promising gene-editing tool for various anticancer
therapies; however, development of a biocompatible, nonviral and efficient delivery of …
therapies; however, development of a biocompatible, nonviral and efficient delivery of …